日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria

一种经过基因工程改造的细菌疗法在临床前模型和肠道高草酸尿症的计算机模拟中降低了尿草酸水平。

Lubkowicz, David; Horvath, Nicholas G; James, Michael J; Cantarella, Pasquale; Renaud, Lauren; Bergeron, Christopher G; Shmueli, Ron B; Anderson, Cami; Gao, Jian-Rong; Kurtz, Caroline B; Perreault, Mylene; Charbonneau, Mark R; Isabella, Vincent M; Hava, David L

Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip

用于治疗人类肠道芯片中苯丙酮尿症的工程活菌疗法的表征

M Tyler Nelson #, Mark R Charbonneau #, Heidi G Coia, Mary J Castillo, Corey Holt, Eric S Greenwood, Peter J Robinson, Elaine A Merrill, David Lubkowicz, Camilla A Mauzy

Transplantability of a circadian clock to a noncircadian organism

昼夜节律生物钟向非昼夜节律生物体的移植性

Anna H Chen, David Lubkowicz, Vivian Yeong, Roger L Chang, Pamela A Silver